Trial Failure Forces Bay Area's Threshold Pharma (THLD) to Cut Almost a Quarter of Workforce
Deaths Lead Boehringer Ingelheim to Cancel $730 Million Cancer Deal With Hanmi Pharma (128940.KS), Hanmi Stock Tanks
Struggling ImmunoGen (IMGN) Eliminates 17% of Workforce After Strategic Review
Helmed by 29-Year-Old CEO, Boston's SQZ Biotech (Pronounced “Squeeze”) Nabs $16 Million and Hires Former Novartis AG (NVS) CAR-T Exec as CBO
Massachusetts's Alnylam (ALNY) Falls After Stopping Development of RNAi Liver Disease Candidate ALN-AAT
Swiss Biotech Giant Lonza Inc. to Open New Facility in Houston Suburb, Will Hire 100 Initially But Hundreds of Jobs to Come
Denmark's LEO Pharma Opens Up Shop in Cambridge
Serial Biotech Bestie Celgene (CELG) Takes Out Swiss Biotech EngMab for $600 Million
Former INSYS Sales Manager is Arrested in Opioid Kickback Scheme
Novo Nordisk A/S (NVO) Aims an Ax at R&D and HQ Staff Functions, Will Cut Up to 1,000 Jobs
Next in a String of Deals, Korea’s Hanmi Pharma (128940.KS) Inks $910M Deal with Genentech (RHHBY)
Pfizer (PFE) on Track to Have 3 Blockbuster Cancer Drugs
SoCal's Arrowhead Pharma (ARWR) Just Snagged a $673.5 Million Heart Deal With Amgen (AMGN)
MediGene AG (MDGEF.PK), bluebird bio (BLUE) Partner Up in $1 Billion+ Cancer Immunotherapy Deal
4 Biotech Stars That Will Beat the Stock Slump
Amgen (AMGN) Waves Golden Tickets at Biotech Startups for Kendall Square Space
With a History of Political Corruption, Rock Creek Pharma Files for Bankruptcy
Pfizer (PFE)'s Newest Immunotherapy Deal Could Propel This Tiny Biotech to New Heights
See All News >
//-->